W
WAVEMAN · COMPANY
TROX · Tronox Holdings Plc
> Ask across nine datasets ⌘K
LIVE
TEAM-2.62% 13F +440META+1.00% 13F +2,694RCG+0.35% CLUSTERUTHR-0.54% 13F +425CRWV+5.68% 13F +694CRM-1.97% 13F +1,019CVNA+1.58% 13F +795TPL-1.11% 13F +444NET-1.96% 13F +711MSTR-1.39% 13F +527DELL+1.50% 13F +1,204CRWD-0.87% 13F +1,383ANET+1.22% 13F +1,324COIN-4.18% 13F +475TEAM-2.62% 13F +440META+1.00% 13F +2,694RCG+0.35% CLUSTERUTHR-0.54% 13F +425CRWV+5.68% 13F +694CRM-1.97% 13F +1,019CVNA+1.58% 13F +795TPL-1.11% 13F +444NET-1.96% 13F +711MSTR-1.39% 13F +527DELL+1.50% 13F +1,204CRWD-0.87% 13F +1,383ANET+1.22% 13F +1,324COIN-4.18% 13F +475
← ALL COMPANIES

TROX

Tronox Holdings plc
PHARMA & BIOTECH · INDUSTRIAL INORGANIC CHEMICALS · CIK 0001530804
FORM 144 · 1☆ WATCH
INSIDER NET · 180D
-
open-market buys minus sells, Form 4 codes P and S
INSIDER BUYERS · 180D
0
CONGRESS BUYERS · 1Y
0
FUNDS ADDED · QTR
131
13F, latest reported quarter
REVENUE GROWTH
-5.7%
XBRL, annual
NET MARGIN
-16.2%
SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST
INSIDERS
no Form 4 purchases or sales on file
CONGRESS
no member of Congress has reported trading it
FUNDS
131 funds added or opened last quarter
more than 75% of Pharma & Biotech
REVENUE
-5.7% year over year
below 65% of Pharma & Biotech
MARGIN
-16.2% net margin
more than 52% of Pharma & Biotech
BUYBACKS
no share repurchases reported
SHORT
no short interest reported
THE SITUATION · EVERY LINE IS ONE RULE OVER ONE DATASET
131 funds added or opened positions in the latest 13F quarter, of 242 holders.
The year, with the filings on it
Total return indexed to 100 over the last 12 months · every marker is a federal filing, placed at its date — hover any marker for the detail
TOTAL 12M RETURN +20.1%
+20.1%12M
-30%+33%+96%+158%2025-092025-102025-122026-032026-052026-072026-09 2026-03-06 · Romano John D sold $669.5K2026-03-06 · Neuman Jeffrey N sold $151.3K2026-03-06 · Srivisal John sold $128.2K2026-03-06 · Turgeon Jean Francois sold $122.5K2026-03-06 · Engle Jeffrey A. sold $96.2K2026-03-05 · Flood Jonathan sold $52.9K2026-03-06 · Flood Jonathan sold $52.7K2026-06-18 · Lucrece De Ridder filed to sell $229.5K
INSIDER SELLFORM 144
INDEXED RETURN, DIVIDEND-ADJUSTED — NOT A PRICE CHART · LARGE TRADES DRAWN FIRST WHEN A NAME FILES HEAVILY
Live price
Daily candles from TradingView, on their licence — no filings are marked on this one
WHY THIS NAME IS ON THE DESK
Insiders have filed to sell — before selling.
The record shows 131 funds added last quarter, $229.5K in planned Form 144 sales. Every figure is a federal filing, dated the day it became public.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector from the SEC's own SIC classification
UTHRCPIXMRNAREGNLLYALNYELFCITRMDGLDNAVRTXNUVL
Insider transactions
Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

No insider purchases or sales are on record for Tronox Holdings plc in the period covered. Source: SEC Form 4 filings, as of 2026-09-06.

INSIDER
FILED
SHARES
VALUE
Romano John D
CEO and Director
SELL
2026-03-06
101,600.0
$669.5K
Srivisal John
SVP, Chief Financial Officer
SELL
2026-03-06
19,461.0
$128.2K
Turgeon Jean Francois
Director
SELL
2026-03-06
18,563.0
$122.5K
Neuman Jeffrey N
SVP, General Counsel & Sec.
SELL
2026-03-06
22,965.0
$151.3K
Engle Jeffrey A.
SVP, Chief Commercial Officer
SELL
2026-03-06
14,575.0
$96.2K
49 TRANSACTIONS ON RECORD

Showing the most recent few. Create a free account to see 44 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders
13F · holdings as of the latest quarter funds have reported
BlackRock, Inc.
11,339,837.0 sh
$71.4M
VAN ECK ASSOCIATES CORP
8,061,905.0 sh
$50.8M
DIMENSIONAL FUND ADVISORS LP
6,656,901.0 sh
$41.9M
PRIMECAP MANAGEMENT CO/CA/
5,468,402.0 sh
$34.5M
VANGUARD CAPITAL MANAGEMENT LLC
5,281,072.0 sh
$33.3M
SCHEDULE 13D/G
No 5%+ ownership filings
Nobody has crossed 5% with a filing obligation. Absence is a fact here, not missing data.
Planned sales · Form 144
Filed before the sale — intent, not a trade
Lucrece De Ridder
FILED 2026-06-18
$229.5K
Fund concentration
N-PORT · funds ranked by how much of THEMSELVES they put in this stock — the conviction number 13F cannot show
Golden Eagle Dynamic Hypergrowth ETF
$459.2K POSITION · AS OF 2026-03-31
1.7%
Knights of Columbus Small Cap Equity Fund
$1.9M POSITION · AS OF 2026-04-30
1.0%
Inspire Small/Mid Cap ETF
$862.3K POSITION · AS OF 2026-02-28
0.3%
VANGUARD PRIMECAP CORE FUND
$40.4M POSITION · AS OF 2026-03-31
0.3%
VANGUARD MARKET NEUTRAL FUND
$1.1M POSITION · AS OF 2026-03-31
0.3%
Vericimetry U.S. Small Cap Value Fund
$229.9K POSITION · AS OF 2026-03-31
0.1%
SEC N-PORT, MONTHLY WITH A ~60-DAY PUBLIC LAG · FUNDS ≥ $10M · % = SHARE OF THE FUND'S OWN BOOK
Fundamentals
Annual figures from XBRL filings · pick a past date to see them exactly as the market knew them then — restatements and all
2025-122024-122023-122022-12
REVENUE$2.9B$3.1B$2.9B$3.5B
GROSS PROFIT$269.0M$515.0M$462.0M$832.0M
OPERATING INCOME$-253.0M$219.0M$186.0M$458.0M
NET INCOME$-470.0M$-48.0M$-316.0M$497.0M
EPS (DILUTED)-2.97-0.31-2.023.16
OPERATING CASH FLOW$60.0M$300.0M$184.0M$598.0M
CASH$199.0M$151.0M$273.0M$164.0M
BUYBACKS—$0$0$50.0M
DIVIDENDS PAID$48.0M$80.0M$89.0M$87.0M
SEC XBRL · FISCAL-YEAR PERIODS · AS KNOWN ON 2026-09-06 · NOBODY ELSE SHOWS FUNDAMENTALS AS OF A PAST DATE
W WAVEMAN

Public filings, honestly analyzed. Official US government sources in one desk — every figure carries the date it was filed, and the methodology is published, backtest included.

SEC FORM 4FORM 13F 13D/GFORM 144XBRL STOCK ACTCONTRACTSFEC CFPBNRC
PRODUCT
DeskBacktester CompaniesAccount
SUPPORT
FAQMethodology Contact
LEGAL
TermsPrivacy Accessibility
© 2026 WAVEMAN · SOURCE: SEC EDGAR & OFFICIAL GOVERNMENT DATA · NOT INVESTMENT ADVICE · CHART BY TRADINGVIEW · UPDATED 2026-09-06 ALL SYSTEMS LIVE FOR MACHINES →